drugset / Trial / NCT04031859

Risk Stratification Procedure for Thromboembolism Prophylaxis

NCT04031859

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The main objective for this study is validation for the proposed risk stratification tool, by evaluating the clinical outcomes for its use post TKR Surgeries. For this objective, the design that is used is Randomized Trial.

Timeline

Start
2018-10-10
Primary completion
2019-07-14
Completion
2019-07-22

Drugs

EvaluationDrugModalityDoseRoute
Background Aspirin Small molecule

Indications

No indication recorded.